Richard Mountfield
General Counsel bei CONSTELLATION PHARMACEUTICALS, INC.
Aktive Positionen von Richard Mountfield
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | General Counsel | - | - |
| AURA BIOSCIENCES, INC. | General Counsel | - | - |
Karriereverlauf von Richard Mountfield
Ehemalige bekannte Positionen von Richard Mountfield
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | General Counsel | - | - |
| CELYAD ONCOLOGY SA | General Counsel | 03.02.2016 | - |
Ausbildung von Richard Mountfield
| University of Aberystwyth | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Belgien | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Richard Mountfield
- Erfahrung
